Literature DB >> 4054276

Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior.

I Strömberg, M Herrera-Marschitz, U Ungerstedt, T Ebendal, L Olson.   

Abstract

Adult rat chromaffin tissue was transplanted into striatum of adult rat recipients whose nigrostriatal dopamine pathway had been lesioned on the grafted side by 6-hydroxydopamine. Long-term survival of the intrastriatal chromaffin grafts and the effects of treatment with nerve growth factor (NGF) was studied histochemically using Falck-Hillarp fluorescence histochemistry and functionally using rotational behavior induced by apomorphine. Small, cortex-free adrenal chromaffin tissue grafts survived permanently in striatum. The number of surviving cells was significantly increased by NGF. NGF treatment also caused transformation of many cells towards a more neuronal phenotype and greatly enhanced the adrenergic nerve fiber outgrowth into host brain tissue. NGF was either injected stereotaxically into the site of transplantation or infused continuously using implantable osmotic minipumps and a stereotaxically placed chronic indwelling dialysis fiber through striatum. The latter arrangement permitted continuous infusion of NGF for 14-28 days and caused a vigorous adrenergic nerve growth response by the grafts directed towards the source of NGF in the brain. There was a clearcut correlation between morphological signs of taking and rotational behavior. Grafts, and in particular grafts treated with NGF, were able to significantly and permanently counteract the rotational behavior induced by apomorphine. There seemed to be a dose relationship between NGF treatments and amount of reduction of asymmetric behavior. NGF treatment probably decreased the relative importance of diffuse release of catecholamines from chromaffin cells in the graft and increased the importance of adrenergic innervation of host striatum by cells in the graft. Immunofluorescence using antibodies against glial fibrillary acidic protein did not reveal any marked gliosis around the grafts nor were there any marked gliotic reactions around chronic indwelling dialysis fibers. We conclude that implantation of chromaffin tissue into striatum in conjunction with NGF treatments is an effective means of counteracting some of the symptoms of experimentally induced unilateral parkinsonism in rats.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054276     DOI: 10.1007/BF00235929

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  15 in total

1.  Fluorescent antibody methods.

Authors:  A H COONS
Journal:  Gen Cytochem Methods       Date:  1958

2.  Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials.

Authors:  E O Backlund; P O Granberg; B Hamberger; E Knutsson; A Mårtensson; G Sedvall; A Seiger; L Olson
Journal:  J Neurosurg       Date:  1985-02       Impact factor: 5.115

3.  The level of nerve growth factor (NGF) as a function of innervation. A correlation radio-immunoassay and bioassay study of the rat iris.

Authors:  T Ebendal; L Olson; A Seiger
Journal:  Exp Cell Res       Date:  1983-10-15       Impact factor: 3.905

Review 4.  Transplantation of monoamine-producing cell systems in oculo and intracranially: experiments in search of a treatment for Parkinson's Disease.

Authors:  L Olson; E O Backlund; W Freed; M Herrera-Marschitz; B Hoffer; A Seiger; I Strömberg
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

5.  Chromaffine cells can innervate brain tissue: evidence from intraocular double grafts.

Authors:  L Olson; A Seiger; R Freedman; B Hoffer
Journal:  Exp Neurol       Date:  1980-11       Impact factor: 5.330

6.  Adrenal medullary implants in the dopamine-denervated rat striatum. II. Acute behavior as a function of graft amount and location and its modulation by neuroleptics.

Authors:  M Herrera-Marschitz; I Strömberg; D Olsson; U Ungerstedt; L Olson
Journal:  Brain Res       Date:  1984-04-09       Impact factor: 3.252

7.  Adrenal medullary implants in the dopamine-denervated rat striatum. I. Acute catecholamine levels in grafts and host caudate as determined by HPLC-electrochemistry and fluorescence histochemical image analysis.

Authors:  I Strömberg; M Herrera-Marschitz; L Hultgren; U Ungerstedt; L Olson
Journal:  Brain Res       Date:  1984-04-09       Impact factor: 3.252

8.  Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites.

Authors:  M Herrera-Marschitz; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1984-02-17       Impact factor: 4.432

9.  Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites.

Authors:  A Björklund; U Stenevi; R H Schmidt; S B Dunnett; F H Gage
Journal:  Acta Physiol Scand Suppl       Date:  1983

10.  Catecholamine content of intracerebral adrenal medulla grafts.

Authors:  W J Freed; F Karoum; H E Spoor; J M Morihisa; L Olson; R J Wyatt
Journal:  Brain Res       Date:  1983-06-13       Impact factor: 3.252

View more
  23 in total

Review 1.  Neural transplantation for Parkinson's disease.

Authors:  I Date; T Ohmoto
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

Review 2.  Transplantation into the human brain: present status and future possibilities.

Authors:  O Lindvall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

3.  Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease.

Authors:  Melissa K McCoy; Terina N Martinez; Kelly A Ruhn; Philip C Wrage; Edward W Keefer; Barry R Botterman; Keith E Tansey; Malú G Tansey
Journal:  Exp Neurol       Date:  2007-11-01       Impact factor: 5.330

Review 4.  Transplantation of embryonic dopamine neurons: what we know from rats.

Authors:  S B Dunnett
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

5.  Production and characterization of biologically active recombinant beta nerve growth factor.

Authors:  F Hallböök; T Ebendal; H Persson
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

6.  Intracerebral xenografts of human mesencephalic tissue into athymic rats: immunochemical and in vivo electrochemical studies.

Authors:  I Strömberg; P Almqvist; M Bygdeman; T E Finger; G Gerhardt; A C Granholm; T J Mahalik; A Seiger; B Hoffer; L Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Basic sciences and clinical neurology: a firsthand experience.

Authors:  G Macchi
Journal:  Ital J Neurol Sci       Date:  1988-08

8.  Ultrastructural evidence for the development of adrenal medullary grafts in the brain.

Authors:  M Jousselin-Hosaja
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

9.  Comparison of adrenal and foetal nigral grafts on drug-induced rotation in rats with 6-OHDA lesions.

Authors:  V J Brown; S B Dunnett
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

10.  The effects of exogenous nerve growth factor on foetal rat adrenal cells in culture.

Authors:  C D Earl; M M Bird
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.